| 注册
首页|期刊导航|中国医学创新|血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值研究

血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值研究

唐桂娥

中国医学创新Issue(32):91-92,93,3.
中国医学创新Issue(32):91-92,93,3.DOI:10.3969/j.issn.1674-4985.2013.32.044

血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值研究

Value of Combining Detection of Serum Progesterone,β-hCG,E2 in Predicting Early Threatened Abortion Outcomes

唐桂娥1

作者信息

  • 1. 皖北煤电集团总医院 安徽 宿州 234000
  • 折叠

摘要

Abstract

Objective:To investigate value of combining detection of serum progesterone,β-hCG,E2 in predicting early threatened abortion outcomes. Method:52 patients with early threatened abortion in our hospital were selected. According to the pregnancy outcome,successful tocolysis group of 42 cases,failure tocolysis group of 10 cases. Serum progesterone,β-hCG,E2 in two groups were compared. Result:Serum progesterone in successful tocolysis group was higher than failure tocolysis group in different gestational weeks,and had significant difference in 6,9 gestational weeks (P<0.05);β-hCG and E2 in successful tocolysis group was significantly higher than failure tocolysis group in 6,9 gestational weeks(P<0.05). Conclusion:Combining detection of serum progesterone,β-hCG,E2 can truely reflect the maternal hormone actual growth. It is helpful to predicte early threatened abortion outcomes.

关键词

孕酮/先兆流产/结局

Key words

Progesterone/Threatened abortion/Outcomes

引用本文复制引用

唐桂娥..血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值研究[J].中国医学创新,2013,(32):91-92,93,3.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文